CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research

Directions Website Contact the organization

CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research Revolutionizing the prevention, treatment, and management of STBBIs

The CTN+ prioritizes regional research capacity by fostering, developing, and supporting research teams in regions across Canada. These regional teams, which include researchers, community members, and Indigenous representation, champion the knowledge needs of those in their local communities. The focus on regional capacity and engagement is informed by the Network’s objective to uphold Indigenous rights and move towards truth and reconciliation, recognizing the power of research and knowledge mobilization to improve health equity across the country.

Evaluating to Learn Together: Practices and Impacts of Patient Partnerships in Research🗓️Wednesday, November 25, 2026, f...
11/10/2026

Evaluating to Learn Together: Practices and Impacts of Patient Partnerships in Research
🗓️Wednesday, November 25, 2026, from 12:00 to 1:00 PM ET

Join Audrey L’Espérance, Assistant Professor at ENAP and a specialist in patient and public engagement in the health research ecosystem, for a webinar on evaluating .

Patient partnership is now at the heart of many research and healthcare improvement initiatives. But how can we assess its quality, reach, and impact? This webinar will provide an overview of emerging and promising approaches and practices to evaluating patient partnership. By exploring different ways to document, understand, and demonstrate the value of partnership experiences, participants will leave with practical ideas to strengthen the impact of their collaborations and better support their current and future projects.

A French translation will be available during the webinar.

Register here: https://tinyurl.com/2mczxycw

Over the past few months, CTN+ researchers and staff have been collaborating with the Healthy Pregnancy Hub  to develop ...
11/09/2026

Over the past few months, CTN+ researchers and staff have been collaborating with the Healthy Pregnancy Hub to develop medication factsheets to help families affected by HIV make informed decisions about their care. Most recently Mia Biondi, Tamara Barnett, and Farnak Canani led the development of this fact sheet on tenofovir disoproxil fumarate (TDF) in pregnancy, one of the most studied antiviral medications, both for HIV and hepatitis B.

💡Learn about the benefits, risks, and other important considerations for taking TDF during pregnancy: https://tinyurl.com/yca9v599

11/05/2026

If you’re someone living with HIV, your perspective is crucial in shaping the direction of future HIV research! 💪

In collaboration with the CTN+ Cure Think Tank, researchers at Monash University are inviting you to take part in a survey about your preferences for future cure treatments and research studies.

The survey will take about 15 minutes, and you'll be asked to choose between different cure or research trial options with varying features. Your choices will help us understand what matters most to you.

📝 Take the survey here: https://bit.ly/4BbndFc

Want to help even more? Share this survey with your networks!

11/05/2026
📰Canada's National Advisory Committee on Immunization (NACI) strongly recommends that all infants should receive routine...
11/04/2026

📰Canada's National Advisory Committee on Immunization (NACI) strongly recommends that all infants should receive routine (HB) Vaccination

The hepatitis B virus can cause acute and chronic infection of the liver. Infants and young children are among the people at highest risk of developing a chronic HB infection.

These new recommendations states that the optimal time to start routine HB vaccination for infants is shaped by current provincial and territorial epidemiology and programmatic considerations. The first dose of the HB vaccine series can be offered within the first 24 hours of birth, or at two months of age, as it is typically the earliest visit in the routine childhood immunization schedule.

Among the members of the NACI Hepatitis Working Group involved in this recommendation was Dr. Carla Coffin, co-lead of the CTN+ Cure & Immunotherapies Think Tank. These recommendations cite research from around the world, including work by CTN+ Researchers Drs. Mia Biondi, Jordan Feld, Joseph Cox, and Naveed Janjua.

Learn more: https://shorturl.at/mwWKl

A recent study (CTN 314) by a team of CTN+ researchers and colleagues compared the prevalence of comorbidities in people...
11/04/2026

A recent study (CTN 314) by a team of CTN+ researchers and colleagues compared the prevalence of comorbidities in people living with over the age of 65, based on the time since they received their HIV diagnosis. They found that the prevalence of many comorbidities had not increased in those who'd been living with HIV for a longer time. However, time since diagnosis did impact prevalence of , , and peripheral neuropathy.

🖥️Le VPH chez les personnes vivant avec le VIH : du risque de cancers au dépistage et à la préventioCe webinaire organis...
11/03/2026

🖥️Le VPH chez les personnes vivant avec le VIH : du risque de cancers au dépistage et à la préventio

Ce webinaire organisé par CATIE explore le lien entre le virus du papillome humain (VPH) et le risque accru de cancers de l’anus, des organes génitaux et de la gorge chez les personnes vivant avec le VIH. La séance permet également de mieux comprendre les données actuelles sur les cancers liés au VPH, les méthodes de dépistage et les obstacles à l’accès à ces services.

Parmi les conférenciers figurent les chercheurs du CTN+, la Dre Alexandra de Pokomandy et le Dr Sean Yaphé.

À visionner ici : https://tinyurl.com/dd63dvbm

🗺️🇨🇦 Global insights, Canadian perspectives: Reflections from AIDS 2026This CATIE webinar brings together Canadian deleg...
11/02/2026

🗺️🇨🇦 Global insights, Canadian perspectives: Reflections from AIDS 2026

This CATIE webinar brings together Canadian delegates from AIDS 2026, including co-lead of the CTN+ Prevention & Testing Think Tank Dr. Darrell Tan, to share insights from the conference and consider what they mean for the HIV response in Canada. Panelists highlight key scientific updates and other developments, reflect on the ideas and discussions that stood out to them and consider their implications for service providers working in HIV across Canada.

Watch now:

Background information on HIV, hepatitis C and STIs in Canada, including basic information, statistics (epidemiology), provincial and national strategies to address HIV, hepatitis C and STIs, and social determinants of health.

Spooky salutations from the CTN+! 🦇Dr. Alia As’sadiq, Dr. David Lessard, Chantal Burelle, and Hansi Peiris at the L'Inst...
10/31/2026

Spooky salutations from the CTN+! 🦇

Dr. Alia As’sadiq, Dr. David Lessard, Chantal Burelle, and Hansi Peiris at the L'Institut de recherche du CUSM - Research Institute of the MUHC are showing off their CTN+ pride in a particularly festive way. 🎃 Pumpkin power!

Are you   and living with HIV?Check out this fact sheet created through a collaboration between CTN+ and the My Healthy ...
10/30/2026

Are you and living with HIV?

Check out this fact sheet created through a collaboration between CTN+ and the My Healthy Pregnancy to learn about the impact HIV can have on your pregnancy, how to manage it, and guidance for safe .

🫄🏼 Learn more: https://tinyurl.com/4by43fst

Address

Vancouver, BC

Alerts

Be the first to know and let us send you an email when CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research:

Shortcuts

Share